Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Compare fees between Total Market and Total World Retirement to understand how costs affect long-term returns and diversification.
28,634 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A focused infrastructure fund rode the AI build-out to roughly 28% gains through mid-2026, underscoring how concentra...
Bank Of America upgrades TripAdvisor to Buy, signaling potential value from Viator and TheFork as Starboard Value exp...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
A Qatar-linked LNG carrier crossed Hormuz, the first export through the strait since the war intensified. The move co...
The Senate Banking Committee advanced the Digital Asset Clarity Act on May 14, 2026, triggering an immediate rally in...
Apple hits a fresh 52-week high as Services revenue climbs and iPhone demand remains strong. The move fuels a buy, ho...
A Texas primary shock sends markets into a risk-off mode as sen. john cornyn becomes a flashpoint for party fault lin...
PulsePlay tops Deloitte’s North American fastest-growing software list, catalyzing investor interest as users earn mo...
FairGambling unveils a new crypto casino review and analytics platform combining on-chain insights, provably fair ver...
Standard Chartered kicks off coverage on Uniswap, signaling a bulls-case for UNI with a target near $100 by 2030. The...